#31. A Phase I/II trial of ATI-2231 with Phase Ia in advanced soild tumor malignancies followed by Phase Ib/II in combination with capecitabine in patients with hormone receptor-positive (HR+) and HER2-negative metastatic breast cancer

Bibliographic Details
Published in:	Journal of Bone Oncology
Main Authors:	Katherine Clifton, Jingqin Rosy Luo, Roberto Civitelli, Stefanie Geisler, Qamar Khan, Ciara O'Sullivan, Ajay Aggarwal, Sheila Stewart, Cynthia Ma
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S2212137424000496

Internet